Kyle Kiser, CEO of Arrive Health, joins the show to highlight his company’s unique approach to lowering costs of prescription drugs for patients in the US. He explains how physicians often make changes to their prescription recommendations based on Arrive Health’s presence as an “invisible component within the EMR,” how they aggregate data to generate clinical alternatives and relevant alternatives to payer preferences, how they maneuver around prior authorizations, the need (or lack thereof) of intermediaries like PBMs, and much more.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
